(Q38281388)

1 September 2017

1 reference

title

Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis (English)

1 reference

acute respiratory distress syndrome

1 September 2017

0 references

1 reference

inferred from title

mesenchymal stem cell

1 reference

2

Lorraine B Ware

1 reference

1 September 2017

3

Michael A Matthay

1 reference

1 September 2017

James Walter

1

1 reference

1 September 2017

language of work or name

1 reference

28 October 2014

1 reference

The Lancet. Respiratory medicine

1 September 2017

published in

1 reference

1 September 2017

volume

2

1 reference

1 September 2017

issue

12

1 reference

1 September 2017

page(s)

1016-1026

1 reference

Mortality rates for patients with acute lung injury/ARDS have decreased over time

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Long-term cognitive impairment and functional disability among survivors of severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Functional disability 5 years after acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Therapeutic potential of mesenchymal stem cells for severe acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Stem cells and cell therapies in lung biology and lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Marrow stromal cells as stem cells for nonhematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Targeted cell replacement with bone marrow cells for airway epithelial regeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Failure of bone marrow to reconstitute lung epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

"Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone marrow-derived cells participate in stromal remodeling of the lung following acute bacterial pneumonia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

In vitro secreting profile of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Effects of intratracheal mesenchymal stromal cell therapy during recovery and resolution after ventilator-induced lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Intravenous infusion of mesenchymal stem cells is associated with improved myocardial function during endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells ameliorate sepsis-associated acute kidney injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Severe sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Concise review: two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Regulation and repair of the alveolar-capillary barrier in acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Angiopoietin signaling in the vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The acute respiratory distress syndrome: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Back to the future: moving beyond "mesenchymal stem cells".

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cells and the stem cell niche: a new chapter

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mesenchymal stem cell-derived microvesicles protect against acute tubular injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Bone and the hematopoietic niche: a tale of two stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Marrow stromal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The MSC: an injury drugstore

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Should publications on mesenchymal stem/progenitor cells include in-process data on the preparation of the cells?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

Exosomes: cell garbage can, therapeutic carrier, or trojan horse?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970217-6

7 January 2021

10.1016/S2213-2600(14)70217-6

Identifiers

DOI

1 reference

1 September 2017

1 reference